Altogether, these findings demonstrate that DHC has cytostatic properties against cancer cells, especially in the presence of TNF-α, by inducing cell cycle arrest in the G1 phase correlated with the downregulation of cyclin D1 expression and RB protein phosphorylation. The gene discussed is TNF; the disease is cancer.